Unlike B12 deficiency, which produces recognisable neurological and haematological symptoms, excess vitamin B12 typically remains asymptomatic and is discovered incidentally during routine blood tests
Human trials limited: Clinical data shows modest or inconsistent results. Unclear mechanisms in humans: Translation from animals to people remains uncertain
Behind these questions, however, lurks a smorgasbord of others relating to BPC-157 itself, a compound which, most likely, few runners had even heard of until it suddenly hit the news
Any compound linked in preclinical work to fibroblast function , vascular support , or repair organisation is naturally going to attract interest from athletes, coaches, and injury-prone training populations
This is another question that pops up frequently